Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2018

STOCKHOLDERS' EQUITY (DEFICIT):

Schedule of share-based compensation, stock options, activity

	Shares Underlying Options		Weighted Average Exercise Price		Weighted average Remaining Contractual Life (years)		Aggregate Intrinsic Value
Outstanding at December 31, 2017		-	$	-		-		-
Acquired in Reverse Merger		133,711		36.42		4.40		-
Granted		68,347		12.24		9.76		-
Outstanding at June 30, 2018		202,058	$	25.74		8.49		-

Schedule of share-based payment award, stock options, valuation assumptions

Fair value of common stock	$10.92-$13.26
Expected volatility	118.10% - 118.83%
Dividend yield	$0
Risk-free interest	2.87% - 3.00%
Expected life (years)	5.33

Schedule of common stock warrant activity

	Number of Warrants			Weighted Average Exercise Price
Outstanding, December 31, 2017		146,358		$	59.04
Acquired, H-1 warrants		50,744			29.04
Acquired, H-3 warrants		14,001			33.12
Granted, H-4 warrants(1)		447,383			3.60
Granted, I warrants		73,178			13.80
Retired, Merger Warrants		(146,357	)		59.04
Outstanding, June 30, 2018		585,307		$	16.98

(1) Excludes 1,342,150 H-4 warrants representing 150% coverage of H-4 warrants granted.